Pasithea Therapeutics Corp. Quarterly report pursuant to Section 13 or 15(d)

Warrants (Details) - Schedule of Warrants Exercisable	Mar. 31, 2024 $ / shares shares
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	769,300
Weighted-average remaining contractual term (years)	2 years 8 months 12 days
Weighted-average exercise price (in Dollars per share) \| $ / shares	$ 82.29
8.13 [Member]
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	1,500
Weighted-average remaining contractual term (years)	9 years 11 months 1 day
1.88 [Member]
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	100,000
Weighted-average remaining contractual term (years)	3 years 4 months 17 days
3.50 [Member]
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	434,000
Weighted-average remaining contractual term (years)	2 years 7 months 24 days
6.00 [Member]
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	13,800
Weighted-average remaining contractual term (years)	2 years 5 months 15 days
6.25 [Member]
Schedule of Warrants Exercisable [Line Items]
Number of Warrants	220,000
Weighted-average remaining contractual term (years)	2 years 5 months 15 days